Transcarinal mediastinal needle biopsy compared with mediastinoscopy

Area of Science:

• Pulmonology
• Oncology
• Diagnostic Imaging

Background:

• Accurate staging of lung cancer is crucial for treatment planning.
• Evaluating mediastinal lymph node involvement is essential for determining cancer dissemination.

Purpose of the Study:

• To compare the diagnostic agreement between transcarinal mediastinal needle biopsy and mediastinoscopy for detecting metastases in subcarinal lymph nodes.
• To assess the utility of transcarinal mediastinal needle biopsy as a screening tool in patients with malignant bronchial lesions.

Main Methods:

• 183 patients with chest roentgenogram abnormalities underwent bronchoscopy with transcarinal mediastinal needle biopsy and mediastinoscopy.
• Analysis focused on the detection of metastases in subcarinal lymph nodes.

Main Results:

• Transcarinal mediastinal needle biopsy identified metastases in subcarinal lymph nodes in 37 of 159 patients with malignant pulmonary lesions.
• Mediastinoscopy showed a similar positive finding rate, but agreement between the two methods was observed in only 20 cases.
• Transcarinal mediastinal needle biopsy is a safe outpatient procedure with no reported complications.

Conclusions:

• Transcarinal mediastinal needle biopsy is a valuable supplement to bronchoscopy for outpatient evaluation of malignant bronchial lesions.
• Positive biopsy results may obviate the need for mediastinoscopy, while negative results necessitate further examination.
• Accurate assessment of mediastinal lymph node status is critical for effective lung cancer treatment planning.